Pre-extensively and extensively drug-resistant tuberculosis, in Libreville, Gabon

被引:0
|
作者
Kombila, U. D. [1 ,3 ]
Boulingui, C. Manomba [2 ,3 ]
N'Gomanda, F. [1 ]
Mavoungou, J. V. Mouity [1 ]
Epossi, C. B. H. Ngea [1 ]
Bivigou, N. [1 ]
Tsioukaka, S. [1 ]
Tshisekedi, J. D. D. [4 ]
Mahoumbou, J. [4 ]
Boguikouma, J. B. [4 ]
机构
[1] Univ Sci Sante Libreville, CHU Libreville, Fac med, Serv med interne, Libreville, Gabon
[2] CHU Libreville, Serv infectiol, Libreville, Gabon
[3] Univ Sci Sante Libreville, Fac med, Libreville, Gabon
[4] Programme Natl TB PNLT, Libreville, Gabon
关键词
Tuberculosis; Drug resistance; Extensively drug-resistant; Libreville; MULTIDRUG-RESISTANT; XDR;
D O I
10.1016/j.rmr.2024.06.011
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction. - Very few studies have been devoted to extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) in Gabon. Aim. - The aim of the present study is to present the epidemiology of pre-XDR and XDR TB and the evolution over time of patients with multidrug-resistant TB. Methods. - This retrospective study covered the activities from 2019 to 2022 of the Nkembo anti-tuberculosis center. Results. - Fifteen patients were eligible, including 11 (73.3%) pre-XDR patients and 4 (26.7%) XDR-TB patients. Three (20.0%) patients had HIV/TB co-infection. The sample consisted of 7 men (46.7%) and 8 women (53.3%), a sex ratio (M/F) of 0.87. The average age was 35.6 years, and the median 34 years, with extremes of 23 and 60 years. Eight patients (53.3%) represented new cases of pre-XDR or XDR-TB tuberculosis. The majority (60%; n = 9) came from deprived neighborhoods with widespread promiscuity. The therapeutic success rate among preXDR patients was 4 (36.4%) versus 2 (50.0%) among XDR-TB patients. Reported mortality occurred 5 (33.3%) patients during treatment, including 3 pre-XDR and 2 XDR-TB patients. In all cases, they died before the end of the first trimester of follow-up. Conclusion. - The high frequency of primary pre-extensively drug-resistant tuberculosis underscores the pervasiveness of resistance to anti-tuberculosis drugs and underlines a pressing need for detection of contact cases and early treatment. (c) 2024 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:542 / 548
页数:7
相关论文
共 50 条
  • [41] Challenge to treat pre-extensively drug-resistant tuberculosis in a low-income country: A report of 12 cases
    Kashongwe, Innocent Murhula
    Mawete, Fina
    Anshambi, Nicole
    Maingowa, Nadine
    Aloni, Murielle
    L'osenga, Luc Lukaso
    Kaswa, Michel
    Kashongwe, Zacharie Munogolo
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2020, 21
  • [42] Drug-resistant and extensively drug-resistant tuberculosis in southern Africa
    Grobusch, Martin Peter
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) : 180 - 185
  • [43] Pre-extensively Drug-Resistant Pulmonary Tuberculosis With a Giant Primary Splenic Hydatid Cyst With Multiple Adverse Drug Reactions
    Yadav, Sankalp
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [44] Extensively and Pre-Extensively Drug Resistant Tuberculosis in Clinical Isolates of Multi-Drug Resistant Tuberculosis Using Classical Second Line Drugs (Levofloxacin and Amikacin)
    Mirza, Irfan Ali
    Khan, Farooq Ahmad
    Khan, Khursheed Ali
    Satti, Luqman
    Ghafoor, Tahir
    Fayyaz, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2015, 25 (05): : 337 - 341
  • [45] Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study
    Diriba, Getu
    Alemu, Ayinalem
    Tola, Habteyes Hailu
    Yenew, Bazezew
    Amare, Misikir
    Eshetu, Kirubel
    Sinshaw, Waganeh
    Abebaw, Yeshiwork
    Meaza, Abyot
    Seid, Getachew
    Moga, Shewki
    Zerihun, Betselot
    Getu, Melak
    Dagne, Biniyam
    Mollalign, Hilina
    Tadesse, Mengistu
    Buta, Bedo
    Wordofa, Niguse
    Alemu, Ephrem
    Erresso, Ashenafi
    Hailu, Michael
    Tefera, Zigba
    Wondimu, Amanuel
    Belhu, Tegegn
    Gamtesa, Dinka Fekadu
    Getahun, Muluwork
    Kebede, Abebaw
    Abdela, Saro
    IJID REGIONS, 2022, 5 : 39 - 43
  • [46] Extensively drug-resistant tuberculosis in South Africa
    Basu, Sanjay
    Galvani, Alison P.
    LANCET, 2007, 369 (9558): : 272 - 273
  • [47] Extensively drug-resistant tuberculosis: epidemiology and management
    Matteelli, Alberto
    Roggi, Alberto
    Carvalho, Anna C. C.
    CLINICAL EPIDEMIOLOGY, 2014, 6 : 111 - 118
  • [48] Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
    Seung, Kwonjune J.
    Keshavjee, Salmaan
    Rich, Michael L.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (09):
  • [49] Linezolid in the treatment of extensively drug-resistant tuberculosis
    Zhang, L.
    Pang, Y.
    Yu, X.
    Wang, Y.
    Gao, M.
    Huang, H.
    Zhao, Y.
    INFECTION, 2014, 42 (04) : 705 - 711
  • [50] Extensively Drug-Resistant Tuberculosis: A Review Article
    Tabarsi, Payam
    Mardani, Masoud
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2012, 7 (03): : 81 - 84